Follow
Susan E Kephart
Susan E Kephart
Pfizer Global R&D, retired
No verified email
Title
Cited by
Cited by
Year
Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth
BW Murray, C Guo, J Piraino, JK Westwick, C Zhang, J Lamerdin, ...
Proceedings of the National Academy of Sciences 107 (20), 9446-9451, 2010
3302010
3, 5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
I McAlpine, J Deal, M Johnson, S Kephart, J Park, W Romines, J Tikhe
US Patent App. 10/910,217, 2005
1612005
Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
SH Reich, TM Bleckman, SE Kephart, WH Romines, MB Wallace
US Patent 6,555,539, 2003
1572003
Silicon-directed aldol reactions. Rate acceleration by small rings
AG Myers, SE Kephart, H Chen
Journal of the American Chemical Society 114 (20), 7922-7923, 1992
1431992
Optimization of orally bioavailable enhancer of zeste homolog 2 (EZH2) inhibitors using ligand and property-based design strategies: identification of development candidate (R …
PP Kung, P Bingham, A Brooun, M Collins, YL Deng, D Dinh, C Fan, ...
Journal of medicinal chemistry 61 (3), 650-665, 2018
1052018
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
SE Kephart, IJ Mcalpine, SH Reich
US Patent 7,008,953, 2006
992006
Discovery of 1-{(3R,4R)-3-[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one …
H Cheng, SK Nair, BW Murray, C Almaden, S Bailey, S Baxi, D Behenna, ...
Journal of Medicinal Chemistry 59 (5), 2005-2024, 2016
982016
Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
SH Reich, TM Bleckman, SE Kephart, WH Romines, MB Wallace
US Patent 6,919,461, 2005
972005
Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
SH Reich, TM Bleckman, SE Kephart, WH Romines III, MB Wallace
US Patent 7,232,912, 2007
942007
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor
K Freeman-Cook, RL Hoffman, N Miller, J Almaden, J Chionis, Q Zhang, ...
Cancer cell 39 (10), 1404-1421. e11, 2021
932021
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
S Kephart, I McAlpine, S Reich
US Patent App. 11/237,446, 2006
932006
Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
S Reich, T Bleckman, S Kephart, W Romines, M Wallace
US Patent App. 11/329,303, 2006
912006
Systematic Structure Modifications of Imidazo[1,2-a]pyrimidine to Reduce Metabolism Mediated by Aldehyde Oxidase (AO)
A Linton, P Kang, M Ornelas, S Kephart, Q Hu, M Pairish, Y Jiang, C Guo
Journal of medicinal chemistry 54 (21), 7705-7712, 2011
822011
Discovery of aryloxy tetramethylcyclobutanes as novel androgen receptor antagonists
C Guo, A Linton, S Kephart, M Ornelas, M Pairish, J Gonzalez, S Greasley, ...
Journal of medicinal chemistry 54 (21), 7693-7704, 2011
782011
Discovery of pyrroloaminopyrazoles as novel PAK inhibitors
C Guo, I McAlpine, J Zhang, DD Knighton, S Kephart, MC Johnson, H Li, ...
Journal of medicinal chemistry 55 (10), 4728-4739, 2012
772012
Pyrazole compounds as RAF inhibitors
JJ Cui, JG Deal, D Gu, C Guo, MC Johnson, RS Kania, SE Kephart, ...
US Patent 7,772,246, 2010
722010
Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors
PP Kung, E Rui, S Bergqvist, P Bingham, J Braganza, M Collins, M Cui, ...
Journal of medicinal chemistry 59 (18), 8306-8325, 2016
672016
Substituted benzamide inhibitors of human rhinovirus 3C protease: structure-based design, synthesis, and biological evaluation
SH Reich, T Johnson, MB Wallace, SE Kephart, SA Fuhrman, ST Worland, ...
Journal of Medicinal Chemistry 43 (9), 1670-1683, 2000
652000
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer
KD Freeman-Cook, RL Hoffman, DC Behenna, B Boras, J Carelli, W Diehl, ...
Journal of Medicinal Chemistry 64 (13), 9056-9077, 2021
632021
Discovery of 2-((1H-benzo [d] imidazol-1-yl) methyl)-4H-pyrido [1, 2-a] pyrimidin-4-ones as novel PKM2 activators
C Guo, A Linton, M Jalaie, S Kephart, M Ornelas, M Pairish, S Greasley, ...
Bioorganic & medicinal chemistry letters 23 (11), 3358-3363, 2013
562013
The system can't perform the operation now. Try again later.
Articles 1–20